NES
FURX

New England Securities’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

New England Securities’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25
Closed -$3K – 1839
2014
Q2 		$3K Sell
25
-20
-44% -$1.96K ﹤0.01% 1499
2014
Q1 		$4K Sell
45
-30
-40% -$2.32K ﹤0.01% 1375
2013
Q4 		$3K Hold
75
– – ﹤0.01% 1399
2013
Q3 		$3K Buy
75
+50
+200% +$2.07K ﹤0.01% 1381
2013
Q2 		$1K Buy
+25
New +$878 ﹤0.01% 1385

New England Securities's FURX Position: Q3 2014 in Review

New England Securities sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 25 shares — an estimated $3K sold.

New England Securities first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $4K in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • New England Securities reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • New England Securities sold 25 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $3K.
  • New England Securities first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • New England Securities's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4K in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on New England Securities's 13F filing for Q3 2014, filed 5 Nov 2014.